State of Wyoming’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13,447
Closed -$109K – 2095
2026
Q1
$109K Sell
13,447
-5,777
-30% -$49.6K 0.01% 1261
2025
Q4
$200K Buy
19,224
+7,052
+58% +$74K 0.02% 980
2025
Q3
$108K Buy
12,172
+3,826
+46% +$27.3K 0.01% 1283
2025
Q2
$48.2K Buy
8,346
+999
+14% +$6.12K 0.01% 1583
2025
Q1
$48.5K Buy
+7,347
New +$57.3K 0.01% 1476
2022
Q3
– Sell
-23
Closed – – 1737
2022
Q2
$0 Buy
23
+3
+15% +$43 ﹤0.01% 2020
2022
Q1
$0 Buy
20
+4
+25% +$58 ﹤0.01% 1920
2021
Q4
$0 Buy
+16
New +$259 ﹤0.01% 1924

Other funds holding KURA

State of Wyoming's KURA Position: Q2 2026 in Review

State of Wyoming sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 13,447 shares — an estimated $109K sold.

State of Wyoming first reported a position in KURA in Q4 2021 and held it in 8 quarters. The position peaked at $200K in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • State of Wyoming reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 13,447 Kura Oncology shares in Q2 2026, an estimated $109K.
  • State of Wyoming first reported a position in Kura Oncology in Q4 2021 and held it in 8 quarters.
  • State of Wyoming's Kura Oncology position peaked at $200K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.